June 4, 2020 / 1:30 PM / a month ago

BRIEF-Melinta Therapeutics To Acquire Tetraphase Pharmaceuticals

June 4 (Reuters) - Tetraphase Pharmaceuticals Inc:

* MELINTA THERAPEUTICS TO ACQUIRE TETRAPHASE PHARMACEUTICALS

* TETRAPHASE PHARMACEUTICALS INC - TERMINATES MERGER AGREEMENT WITH ACELRX TO ENTER INTO MERGER AGREEMENT WITH MELINTA

* TETRAPHASE PHARMACEUTICALS - AGREEMENT PROVIDES FOR $39.0 MILLION UPFRONT IN CASH PLUS POTENTIAL CONTINGENT VALUE RIGHTS CASH PAYMENTS OF UP TO $16.0 MILLION

* TETRAPHASE PHARMACEUTICALS - BOARD OF TETRAPHASE UNANIMOUSLY RECOMMENDS STOCKHOLDERS TENDER SHARES IN MELINTA TENDER OFFER ONCE IT IS COMMENCED

* TETRAPHASE PHARMACEUTICALS INC - PAID ACELRX A TERMINATION FEE IN AMOUNT OF $1.8 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below